FDAnews
www.fdanews.com/articles/124320-biomarin-to-buy-lead-for-97-million

BioMarin to Buy Lead for $97 Million

February 5, 2010
Enzyme drugmaker BioMarin Pharmaceutical said it is buying LEAD Therapeutics, a company testing a drug treatment for rare cancers, in a deal worth up to $97 million.
Forbes